As the COVID-19 pandemic unfolds, issues of corporate influence and regulatory oversight surrounding Pfizer's vaccine have surfaced. A 2023 Danish study revealed 'blue batches' of the vaccine linked to adverse events, raising concerns about accountability and safety standards. While critics refuted the findings, alleging fraud or incompetence, others suggest that high-risk demographics may skew data. Notably, a young critic’s defense of Pfizer hints at possible ghostwriting, deepening suspicions about the integrity of public health information during the crisis.
Recent revelations about "hot lots" - deadly batches of vaccines linked to disproportionate adverse events - have raised alarming questions about transparency, accountability and the role of ghostwriters in shaping public perception.
The Danish study, led by Vibeke Maniche, identified "blue batches" that accounted for just 4% of doses but were linked to 50% of vaccine-related deaths.
Collection
[
|
...
]